Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

New therapeutic agents for neurological disorders reported in recent patent literature

Nov. 18, 2008

Studies show analgesic efficacy of ARRY-797 in postsurgical dental pain

Nov. 18, 2008

New glycine transporter GlyT1 inhibitor profiled at Merck & Co.

Nov. 17, 2008

FDA approves Banzel as adjunctive treatment for Lennox-Gastaut syndrome

Nov. 17, 2008

Sygnis receives European orphan drug status for AX-200 in spinal cord injury

Nov. 17, 2008

FDA accepts TheraQuest's IND for abuse deterrent opioid TQ-1015

Nov. 17, 2008

Esreboxetine improves pain, function and fatigue in double-blind fibromyalgia study

Nov. 17, 2008

Seroquel approved in Europe for new indications in bipolar disorder

Nov. 13, 2008

Lipocine completes clinical study establishing feasibility of once-daily ziprasidone

Nov. 12, 2008

Anesiva discontinues Zingo, reports results from phase III trial of Adlea

Nov. 12, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 10, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026